Cell and Gene Therapy Catapult

Stevenage, UK
National Center
CAR-T Cell Therapy AAV
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
59.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (1) ○ EMA GMP ○ MHRA GMP

Quick Facts: Cell and Gene Therapy Catapult

Signal Score
59.0/100 (as of 2026-04-29)
Quality Compliance
Assessment pending
Headquarters
Stevenage, UK
Modalities
CAR-T, Cell Therapy, AAV
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Cell and Gene Therapy Catapult

CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Stevenage, UK
Modalities: CAR-T, Cell Therapy, AAV
Capacity assessment: 58.0/100
Sites: Stevenage, UK
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press1 articles
1 manufacturing site: Stevenage, UK
Modalities: CAR-T, Cell Therapy, AAV
Capacity assessment: 58.0/100

Recent News 1 articles

general 2026-02-19
Cell and Gene Therapy Catapult Establishes Technology Advisory Board - The Medicine Maker
Cell and Gene Therapy Catapult Establishes Technology Advisory Board  The Medicine Maker
Source →

Frequently Asked Questions About Cell and Gene Therapy Catapult

What is Cell and Gene Therapy Catapult's CDMO Signal Score?
Cell and Gene Therapy Catapult has a Signal Score of 59/100, based on quality, operations, financial stability, and capacity data.
Evaluating Cell and Gene Therapy Catapult for a manufacturing program?
Use the free AI matchmaker to compare Cell and Gene Therapy Catapult against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
CAR-T CDMOs → Cell Therapy CDMOs → AAV CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 83.7
CAR-T, Cell Therapy, AAV, ADC, Monoclonal Antibody
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 80.6
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein
OmniaBio
Hamilton, ON
Signal Score: 79.5
AAV, Lentiviral, CAR-T, Cell Therapy
Made Scientific
Newark, NJ
Signal Score: 61.5
CAR-T, Cell Therapy, AAV